BBC presenter runs 10k in Crocs in memory of younger brother
He wore Crocs during the race to 'defy expectations' and to encourage people to 'show up for yourself' after his 31-year-old brother's death last year, and regularly wears them during his appearances on television.
In 2024, Mr Campbell spoke openly about losing his younger sibling to an aggressive form of brain cancer, despite trying sonodynamic therapy in New York, describing his brother's health battle as 'heroic'.
Danny Campbell ran the race with a copy of a book written by his late brother, Duncan (Callum McKenzie/PA Wire)
The race, which started at the Riverside Museum and ended in Glasgow Green, is designed to get men of all ages talking about their mental health.
Mr Campbell, a father-of-three, said: 'I ran the race in my brother's honour. Every squeaky step, Dunk was with me.
'He faced life's hardest challenges with humour, courage, and zero regard for convention. He made sure we laughed, even when things got impossibly hard. I'm just trying to follow in his footsteps.
'My Crocs are now a symbol of not giving a toss about other people's expectations.
'It's about showing up as yourself — and creating space for other people to do the same.
'Thanks to everyone who donated, cheered, or just shook their head in disbelief. I hope it made people smile. And maybe think about someone they could check in on today.'
Writing on a JustGiving page, he said: 'I'm doing this in memory of my little brother and to encourage others to share their struggles.
'Dunk fought a tough battle with cancer and had a profoundly positive impact on so many people. He was charismatic, quick-witted, honest and caring.'
Mr Campbell, an ambassador for The Social Hub Glasgow, said that doing the race in Crocs was 'a silly way to say something serious'.
He raised £750 for the Mental Health Foundation, which praised his efforts at 'normalising conversations around mental health'.
Julie Cameron, associate director for Scotland at Mental Health Foundation, said: 'We're incredibly grateful to Danny for taking on this challenge, raising both awareness and vital funds for the Mental Health Foundation.
'His message encouraging people, especially men, to talk about their struggles and seek support is more important than ever.
'While awareness has grown, stigma still holds many back from opening up about their struggles.
'Normalising conversations around mental health is crucial, and if an architect running a 10K in Crocs sparks those discussions, that's a win.'
To donate, visit justgiving.com/page/danny-campbell
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Metro
18 hours ago
- Metro
Man's deadly brain cancer disappears after experimental drug trial
Chloe Johnson Published July 23, 2025 4:47pm Link is copied Comments Ben Trotman, 43, was diagnosed with glioblastoma, an aggressive form of brain cancer where patients typically die within 12-to-18 months, in October of 2022. Now, however, he is showing no signs of the disease after being administered the immunotherapy drug ipilimumab (Picture: Marie Mangan/UCLH/PA Wire) Two months are receiving ipilimumab, Trotman married his wife Emily and, in April 2025, they welcomed their daughter, Mabel. At the time of diagnosis, a family friend recommended that Trotman should be referred to The National Hospital for Neurology and Neurosurgery at UCLH, where they met consultant medical oncologist Dr Paul Mulholland. Mulholland recruited Trotman to a clinical trial he was running, in which Trotman would be the first in the world to receive the immunotherapy drug ipilimumab to treat glioblastoma prior to standard treatment. Now aged 43 - two years and eight months on from having this treatment - Ben's scans are clear with no signs of tumour (Picture: UCLH) Trotman's wife, Emily, said: 'Getting this diagnosis was the most traumatic experience. We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live. Had we not met Dr Mulholland, that would have been it for us. We felt we had a lucky break in an otherwise devastating situation' (Picture: Marie Mangan/UCLH/PA Wire) Now, a new immunotherapy trial for this deadly form of cancer is now set to enrol 16 people over an 18-month period, following the remarkable outcome which saw Trotman's tumour vanish. The NHS study has been established in memory of Baroness Margaret McDonagh, who succumbed to the disease. Dame Siobhain McDonagh MP, sister to the Baroness, led a fundraising campaign to raise more than £1 million to cover the costs of the new trial. Patients diagnosed with glioblastoma will receive the immunotherapy drug ipilimumab prior to standard treatment, building on a previous study involving the same drug (Picture: Getty) Dame McDonagh, MP for Mitcham and Morden and chair of the all-party parliamentary group on brain tumours, said: 'My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma. Changing this was Margaret's final campaign and one that I have continued in her memory. I am so grateful to the many people who knew and respected Margaret, who have come together and helped to raise funds and campaign for this new trial that we are calling Margaret's Trial' (Picture: Marie Mangan/UCLH/PA Wire) Consultant medical oncologist, Dr Paul Mulholland, who is leading the new trial, said of Ben's recovery: 'It is very unusual to have a clear scan with glioblastoma, especially when he didn't have the follow-up surgery that had been planned to remove all of the tumour that was initially visible on scans. We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumour at bay – and it has so far, which we are delighted to see' This new treatment will be administered at the NIHR UCLH's Clinical Research Facility and the National Hospital for Neurology and Neurosurgery. The patients will receive the drug ipilimumab before proceeding to standard treatments that may include surgery, radiotherapy and chemotherapy. Mulholland said of the trial: 'The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy' (Picture: Getty) Your free newsletter guide to the best London has on offer, from drinks deals to restaurant reviews.
Scotsman
5 days ago
- Scotsman
New AI tool could speed up skin cancer diagnoses in remote parts of world
Technology would enable early detection without the need for direct access to dermatologists Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... A researcher at a Scottish university has developed AI tools that could give people in remote areas of the world access to fast and potentially life-saving skin cancer diagnoses. Tess Watt , the PhD student at Heriot-Watt University in Edinburgh who led the project to develop the technology, said it is intended to enable early detection of skin conditions anywhere in the world, and without the need for direct access to dermatologists. The technology also works without internet access. Advertisement Hide Ad Advertisement Hide Ad PhD student Tess Watt, who has developed AI tools that could give people in remote areas of the world access to fast and potentially life-saving skin cancer diagnoses | Heriot-Watt University/PA Wire The system involves a patient taking a photograph of their skin complaint using a small camera attached to a Raspberry Pi device - a cheap, energy-efficient handheld computer that is capable of storing vast amounts of information. The photograph is analysed in real-time using the latest state-of-the-art image classification, comparing it to an enormous dataset of thousands of images stored on the device to reach a diagnosis. The findings are then shared with a local GP service to begin a suitable treatment plan. Advertisement Hide Ad Advertisement Hide Ad The project is understood to be the first of its kind to combine AI medical diagnosis with the aim of serving remote communities. Ms Watt explained: "Healthcare from home is a really important topic at the moment, especially as GP wait times continue to grow. "If we can empower people to monitor skin conditions from their own homes using AI, we can dramatically reduce delays in diagnosis." A prototype of the device has already been demonstrated at Heriot-Watt's advanced health and care technologies suite. Advertisement Hide Ad Advertisement Hide Ad Up to 85 per cent accurate The research team said the tool is up to 85 per cent accurate in its diagnostic capabilities, but they hope to increase this further by gaining access to more skin lesion datasets, aided by advanced machine tools. Ms Watt is also in talks with NHS Scotland to begin the ethical approval process for testing the technology in real-world clinical settings. "Hopefully in the next year or two, we'll have a pilot project under way," she said, noting medical technology often takes years to move from prototype to implementation. Advertisement Hide Ad Advertisement Hide Ad She added: "By the time I finish my PhD, three years from now, I'd love to see something well into the pipeline that's on its way to real-world use." The university said the long-term vision is to roll the system out first across remote regions of Scotland , before expanding to global areas with limited access to dermatological care. It added the technology could also offer vital support to patients who are infirm or unable to travel, allowing loved ones to assist with capturing and submitting diagnostic images to GPs. Advertisement Hide Ad Advertisement Hide Ad Ms Watt's academic supervisor, Dr Christos Chrysoulas , said: "E-health devices must be engineered to operate independently of external connectivity to ensure continuity of patient service and safety. "In the event of a network or cloud service failure, such devices must fail safely and maintain all essential clinical operations without functional degradation. "While auxiliary or non-critical features may become temporarily unavailable, the core diagnostic and even therapeutic capabilities must remain fully operational, in compliance of course with safety and regulatory requirements.
The Sun
5 days ago
- The Sun
Iconic Scots comedian and ex-radio host diagnosed with prostate cancer as stand-up urges other men to get checked
SCOTS comedy icon Fred MacAulay has been diagnosed with prostate cancer. The standup has had regular checks after his father and big brother were diagnosed with the illness. 2 The 68-year-old hadn't been displaying any symptoms but following his most recent check-up, doctors broke the news to him. But the radio host is adamant that he won't let his diagnosis get to him. Fred told The Sunday Post: "I'm determined not to let a prostate cancer diagnosis get me down. I've even managed to stay away from the internet because I'd just scare myself to death. "It wasn't until my own father developed prostate cancer and then my older brother was diagnosed too that I actively decided I'd better do something to explore whether I was also at risk." The comic's father, also named Fred, passed away aged 73 in 2002. He had faced a lengthy battle with prostate cancer and mesothelioma. Fred said: "When my brother Duncan, who is now 72, was diagnosed with prostate cancer eight years ago, I thought it was about time I took the hint and got checked out. "I'm lucky enough to be able to get the incredibly accurate MRI tests, which can show things up quickly. "When it became clear I'm more at risk because of the prevalence of prostate cancer in my family, I've been getting tested every couple of years. "After the last test a few weeks ago, my doctors got back to me and advised further action was needed. "Although I've not had any symptoms, the final tests came back positive just a few days ago and I am waiting to see what the medical team advise is my next step." Fred is focused on spreading awareness about prostate cancer and is urging other men to get checked out. David Beckham is left with a huge BALD patch after DIY haircut blunder - and wife Victoria admits 'it looks terrible' He said: "I hope by speaking up this will encourage other men to get checked out too. It could save their lives. "My brother and my family and friends are all good about speaking up about prostate cancer. But I know not everyone is. "It's always been a scary thing to talk about, but with all the progress in medicine, the best thing to do is be aware, get tested and catch it quickly as it gives you the best possible chance of beating it." Fred, from Perth, previously presented the Macaulay and Co. daily show on BBC Radio Scotland. The father-of-three has worked as an accountant and is married to his teenage sweetheart, Aileen.
